Acadia Healthcare (ACHC) Scheduled to Post Earnings on Wednesday

Acadia Healthcare (NASDAQ:ACHC) will be issuing its quarterly earnings data after the market closes on Wednesday, May 1st. Analysts expect the company to announce earnings of $0.80 per share for the quarter. Parties interested in participating in the company’s conference call can do so using this link.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, February 28th. The company reported $0.85 EPS for the quarter, topping the consensus estimate of $0.80 by $0.05. The firm had revenue of $742.80 million for the quarter, compared to the consensus estimate of $727.60 million. Acadia Healthcare had a negative net margin of 0.74% and a positive return on equity of 11.21%. The business’s quarterly revenue was up 10.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.70 earnings per share. On average, analysts expect Acadia Healthcare to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Acadia Healthcare Trading Up 0.7 %

Acadia Healthcare stock opened at $70.74 on Wednesday. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.67 and a quick ratio of 0.67. The company has a market capitalization of $6.54 billion, a price-to-earnings ratio of -282.95, a PEG ratio of 2.07 and a beta of 1.31. Acadia Healthcare has a one year low of $66.49 and a one year high of $87.77. The company’s fifty day moving average price is $78.68 and its two-hundred day moving average price is $77.72.

Insiders Place Their Bets

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the firm’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total transaction of $188,114.17. Following the completion of the transaction, the director now owns 46,074 shares in the company, valued at $3,934,258.86. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 2.80% of the company’s stock.

Analyst Ratings Changes

ACHC has been the topic of several analyst reports. Mizuho increased their target price on shares of Acadia Healthcare from $77.00 to $84.00 and gave the stock a “neutral” rating in a research report on Wednesday, March 6th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $94.00 price target on shares of Acadia Healthcare in a research report on Monday, March 4th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $90.00 price target on shares of Acadia Healthcare in a research report on Tuesday, March 5th. Barclays initiated coverage on Acadia Healthcare in a research report on Wednesday, March 6th. They issued an “overweight” rating and a $100.00 price target on the stock. Finally, UBS Group raised their price target on Acadia Healthcare from $88.00 to $102.00 and gave the company a “buy” rating in a research report on Wednesday, February 28th. Three investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, Acadia Healthcare has a consensus rating of “Moderate Buy” and an average target price of $94.75.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.